KATHRYN ACKERMAN: Open Payments
NPI 1043654932 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 27 payments from 10 companies in 2025. Trend: 2023 $443 · 2024 $366 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $212 |
| Sage Therapeutics, LLC | 4 | $102 |
| Hologic Sales and Service, LLC | 3 | $91 |
| Exact Sciences Corporation | 4 | $80 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $57 |
| Supernus Pharmaceuticals, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $6 |
Products named: Veozah, ZURZUVAE, Cologuard Collection Kit, APTIMA, Qelbree, MOUNJARO, THINPREP 2000 PROCESSOR, Mirena.
Industry payments across TX — which companies pay providers there.
